Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds
Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds
Not yet recruiting · NCT07223892 · Registry updated 2025-11-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds | Diabetes Complications, Diabetic Foot, Foot Ulcer, Leg Ulcer, Skin Ulcer, Skin and Connective Tissue Diseases, Surgical Wound, burn, cardiovascular disorder, decubitus ulcer, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, injury, skin disorder, vascular disorder | Not yet recruiting | Phase 3 | 2025-11-06 | NCT07223892 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bardia Anvar | 1 |
| Carbon Life Sciences | 1 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||